News Room

New research in the INFORMS journal Management Science finds that the U.S. Food and Drug Administration (FDA) could enhance public safety by employing new data-driven approaches to identify adverse effects of drugs faster and more reliably, which would improve the regulatory decision-making and oversight processes. This approach would substantially contrast with the current FDA approaches for monitoring drug safety, which suffers major drawbacks (e.g., they are based on voluntary reports that can result in inaccurate or untimely decisions).

Commercial brokers have always crunched data to make sure an investment makes financial sense. But high-tech analytics can take that analysis to a new level.

Opher Baron, operations management orofessor, Rotman School of Management, joins BNN Bloomberg to discuss the global supply chain disruption and what businesses can expect in the coming months. He also notes that it will take time for firms around the world to work through altering their supply chains.

Can't find what you need at the store again? You're not alone. As the world reaches the two-year mark of the COVID-19 pandemic, more items are becoming scarce because of a supply chain shortage across the globe.

President Joe Biden on Wednesday announced a plan to clear the backlog of container ships off the coast of Southern California by launching 24-hour operations at the port of Los Angeles. Mike O’Sullivan reports.